2025-523391-22-01RecruitingPhase 4
The Role of Beta-Blockade During Cardiac CT in Patients with Atrial Fibrillation
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- First submitted
- 28 Aug 2025
- Start date
- 20 Jan 2026
- Lead sponsor
- Semmelweis University
- EU CT number
- 2025-523391-22-01
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 136
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Semmelweis University | Budapest XII | Hungary | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.